Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 756 participants.

Also called NCT01848873

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 756 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01848873
Other papers using this trial's data
  • Blood pressure and homocysteine-lowering effects of the amlodipine/folic acid combination in patients with hypertension and serum homocysteine concentration ≥10 μmol/l (H-type hypertension): a multicenter, randomized, double-blind, parallel-controlled clinical trial Journal of hypertension, 2026-12-01 DOI, PubMed 42861767

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01848873. Randomized; quadruple masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2013-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine
Condition
Essential Hypertension
Intervention (Drug)
Amlodipine
Intervention (Drug)
amlodipine-FA tablet, low dose group
Intervention (Drug)
amlodipine-FA tablet ,high dose group
Lead sponsor
Shenzhen Ausa Pharmed Co.,Ltd (class: industry)
Collaborator
Peking University First Hospital (class: other)
Collaborator
Chinese PLA General Hospital (class: other)
Collaborator
Capital Medical University (class: other)
Collaborator
Fudan University (class: other)
Collaborator
Ruijin Hospital (class: other)
Collaborator
Nanchang University (class: other)
Collaborator
First Affiliated Hospital of Fujian Medical University (class: other)
Collaborator
First Affiliated Hospital of Harbin Medical University (class: other)
Collaborator
China Medical University, China (class: other)
Collaborator
Xi'an Jiaotong University (class: other)
Collaborator
Xuzhou Medical University (class: other)
Collaborator
Anhui Medical University (class: other)
Collaborator
Huazhong University of Science and Technology (class: other)
Collaborator
West China Hospital (class: other)
Collaborator
Guangdong Provincial People's Hospital (class: other)
Collaborator
Second Affiliated Hospital, Zhejiang University, School of Medicine (class: other)

Registry records

Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry organizations 12

Record details

Record id
cardio:ct-nct01848873
Content hash
99a70cf2befe4e8b0e8226a270e02fde0422590cd1d110889725b2f067e73573